Overview

The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.

Eligibility

Inclusion Criteria:

• Participants must be at least 18 years of age
• no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma.

Exclusion Criteria:

• Pregnant women and prisoners will be excluded from the study.
• Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded.